Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After TAVI

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Symptomatic Aortic Valve Stenosis
Trial Locations (1)

40225

Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Duesseldorf, Düsseldorf

All Listed Sponsors
lead

Klinik für Kardiologie, Pneumologie und Angiologie

OTHER

NCT01801098 - Electrophysiologic HV-interval as a Predicor for Permanent Pacemaker Implantation After TAVI | Biotech Hunter | Biotech Hunter